In addition, a kit for detecting clear cell type renal carcinoma is disclosed. The kit includes an agent capable of cleaving N-linked sugar residues, lactosamine residues, sialic acid, or combinations thereof and a biological agent which binds to Na, K-ATPase....
PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis. Diagn Pathol. 2015; 10(1): 189. Google Scholar, Medline6... JS Pyo,G Kang,JY Kim - 《International Journal of Biological Markers》 被引量: 4发表: 2018年 High PD-L1 expression is associated wit...
The histologic diagnosis may be challenging as the presence of small blue cells on biopsy may be mistaken for a lymphoma involving the prostate or a small cell carcinoma of the prostate, diagnostic possibilities that are statistically ... S Logani,RA Cabrera,MB Amin - 《Pathology Case Reviews》...
网络释义 1. 肾透明细胞癌 肾透明细胞癌(Clear Cell Renal Cell Carcinoma)是肾细胞癌中最常见的病理类型,约占70%～80%,因此筛选和鉴定肾透明细胞癌 … cdmd.cnki.com.cn|基于8个网页 2. 透明细胞肾细胞癌 透明细胞肾细胞癌(clear cell renal cell carcinoma), 多房性囊性透明细胞肾细胞癌(multilocular cl...
Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer. Prognosis for ccRCC is generally poor since it is largely resistant to chemo- and radiotherapy. Many studies suggested that cancer stem cells/tumor initiating cells (CSCs/TICs) are responsible for development of tumor, dise...
Clear cell renal cell carcinoma (CCRCC) is a renal cortical tumor typically characterized by malignant epithelial cells with clear cytoplasm and a compact-alveolar (nested) or acinar growth pattern interspersed with intricate, arborizing vasculature. A variable proportion of cells with granular eosinophil...
low molecular weight cytokeratin and CD10.The tumor cells did not express PSA or PAP and was negative to high molecular weight cytokeratin.Conclusion Renal-type clear cell carcinoma of the prostate is a rarely distinct variant of the prostate carcinoma.This tumor should be distinguished from others...
Clear cell renal cell carcinoma (ccRCC) is a complex disease with remarkable immune and metabolic heterogeneity. Here we perform genomic, transcriptomic, proteomic, metabolomic and spatial transcriptomic and metabolomic analyses on 100 patients with ccRC
PCD-related long non-coding RNAs (PRLs) are rarely investigated in relation to clear cell renal carcinoma (ccRCC). As part of this study, we evaluated the immunological potential of PRL signatures as a biomarker for ccRCC prognosis and immunological function. Materials and methods Data were downl...
313、囊性肾细胞癌(cystic renal cell carcinoma,CRCC):病例&解析 312、肝脏神经内分泌肿瘤:病例&解析 311、眼眶淋巴瘤:病例&解析 310、Castleman病(Castleman Disease,CD):病例&解析 309、弥漫性腱鞘巨细胞瘤:病例&解析 308、胃神...